NDC Package 60219-1410-6 Apremilast

Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
60219-1410-6
Package Description:
60 TABLET, FILM COATED in 1 BOTTLE
Product Code:
Proprietary Name:
Apremilast
Non-Proprietary Name:
Apremilast
Substance Name:
Apremilast
Usage Information:
This medication is used to treat a certain type of arthritis (psoriatic arthritis). Apremilast is also used to treat a certain type of skin condition (moderate to severe plaque psoriasis). Apremilast belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors. For the treatment of psoriatic arthritis, it decreases pain and swelling, and may help improve flexibility in the affected joints. For the treatment of plaque psoriasis, it may help to reduce the redness, thickening, and scaling of the skin that occurs with this condition. Apremilast is also used to treat mouth sores in people who have Behcet's disease. It helps to reduce the pain and improve the healing of these mouth sores.
11-Digit NDC Billing Format:
60219141006
NDC to RxNorm Crosswalk:
  • RxCUI: 1492732 - apremilast 10 MG Oral Tablet
  • RxCUI: 1492740 - apremilast 20 MG Oral Tablet
  • RxCUI: 1492744 - apremilast 30 MG Oral Tablet
  • RxCUI: 1492747 - {4 (apremilast 10 MG Oral Tablet) / 4 (apremilast 20 MG Oral Tablet) / 19 (apremilast 30 MG Oral Tablet) } Pack
  • RxCUI: 1492747 - apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (19) Oral Tablet 14-Day Pack
Product Type:
Human Prescription Drug
Labeler Name:
Amneal Pharmaceuticals Ny Llc
Dosage Form:
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
ANDA211782
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
07-05-2021
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 60219-1410-6?

The NDC Packaged Code 60219-1410-6 is assigned to a package of 60 tablet, film coated in 1 bottle of Apremilast, a human prescription drug labeled by Amneal Pharmaceuticals Ny Llc. The product's dosage form is tablet, film coated and is administered via oral form.

Is NDC 60219-1410 included in the NDC Directory?

Yes, Apremilast with product code 60219-1410 is active and included in the NDC Directory. The product was first marketed by Amneal Pharmaceuticals Ny Llc on July 05, 2021 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 60219-1410-6?

The 11-digit format is 60219141006. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-160219-1410-65-4-260219-1410-06